Growth Metrics

bioAffinity Technologies (BIAF) Change in Account Payables (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Change in Account Payables for 4 consecutive years, with -$178860.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 187.52% to -$178860.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$225410.0 through Dec 2025, down 158.93% year-over-year, with the annual reading at -$225410.0 for FY2025, 158.93% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$178860.0 at bioAffinity Technologies, up from -$229076.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $577474.0 in Q3 2023, with the low at -$435285.0 in Q3 2022.
  • Average Change in Account Payables over 4 years is $16077.8, with a median of -$23940.5 recorded in 2022.
  • The sharpest move saw Change in Account Payables crashed 1248.49% in 2023, then soared 1565.44% in 2024.
  • Over 4 years, Change in Account Payables stood at $195360.0 in 2022, then crashed by 315.67% to -$421337.0 in 2023, then soared by 148.51% to $204373.0 in 2024, then plummeted by 187.52% to -$178860.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$178860.0, -$229076.0, and -$211741.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.